Prescription Opioid Misuse: Effective Methods for Reducing the Epidemic

被引:0
|
作者
Li X. [1 ,3 ]
Shorter D. [2 ,3 ]
Kosten T. [2 ,3 ]
机构
[1] Harris Health - Ben Taub General Hospital, 1504 Taub Loop, Houston, 77030, TX
[2] Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd, Houston, 77030, TX
[3] Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, One Baylor Plaza, Houston, 77030, TX
关键词
Abuse-deterrent formulations; Buprenorphine; Oxycodone; Prescription opioid abuse;
D O I
10.1007/s40501-015-0045-6
中图分类号
学科分类号
摘要
Prescription opioid misuse has been a significant epidemic during the past decade. Formulations of prescription opioids with different mechanisms of abuse-deterrence have been developed or are currently under development. Given that these medications are substantially more difficult to use in an illicit fashion and minimize the potential for euphoria and/or create an aversive experience when over-ingested, they represent an important next step in pharmacological innovation. Immediate decreases in nonmedical use and in associated overdose mortality and adverse events have been observed after a highly abused opioid, OxyContin, was changed into an abuse-deterrent formulation. However, this reduction in OxyContin use may have simply shifted the drug of choice towards other more easily misused opioids, suggesting that a change in formulation alone will not be sufficient in controlling the epidemic. To control prescription opioid misuse requires treating populations with opioid use disorder and preventing the development of opioid abuse or dependence in unaffected populations. Buprenorphine with naloxone has been designed as an abuse-deterrent formulation, while also demonstrating significant efficacy in treating opioid use disorder. Thus, the dissemination of buprenorphine treatment can be a helpful step in reducing the current epidemic. Other strategies to reduce the epidemic include limiting the availability of leftover prescription opioids through drug take back programs, monitoring physician prescriptions through state prescription monitoring programs, and implementing evidence-based practices in pain management. Increased referral of patients with chronic nonmalignant pain to comprehensive pain rehabilitation programs can also reduce healthcare utilization while improving patient outcomes. Also, routine screening for prescription misuse and referral for addictions treatment must become a standard practice in order to ensure patient safety and create early opportunities for intervention. © 2015, Springer International Publishing AG (outside the USA).
引用
收藏
页码:122 / 135
页数:13
相关论文
共 50 条
  • [1] The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse
    Soffin, Ellen M.
    Lee, Bradley H.
    Kumar, Kanupriya K.
    Wu, Christopher L.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2019, 122 (06) : E198 - E208
  • [2] Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic
    Faller, Rachel W.
    Erausquin, Jennifer Toller
    McCoy, Thomas P.
    [J]. SUBSTANCE USE & MISUSE, 2020, 56 (02) : 333 - 337
  • [3] Gender differences in prescription opioid use and misuse: Implications for men's health and the opioid epidemic
    Silver, Elisabeth R.
    Hur, Chin
    [J]. PREVENTIVE MEDICINE, 2020, 131
  • [4] INTENTION TO MISUSE PRESCRIPTION OPIOIDS IS ASSOCIATED WITH PRIOR OPIOID USE AND PRESCRIPTION OPIOID MISUSE PERCEPTIONS
    Romberg, Alexa R.
    Tulsiani, Shreya
    Liu, Michael
    Hair, Elizabeth C.
    Vallone, Donna
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2020, 54 : S655 - S655
  • [5] Social media as an emerging tool for reducing prescription opioid misuse risk factors
    Young, Sean D.
    Lee, Sung-Jae
    Perez, Hendry
    Gill, Navkiran
    Gelberg, Lillian
    Heinzerling, Keith
    [J]. HELIYON, 2020, 6 (03)
  • [6] The prescription drug misuse and abuse epidemic
    Thompson, Megan E.
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2012, 52 (05) : 564 - 566
  • [7] Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids
    Bedene, Ajda
    Dahan, Albert
    Rosendaal, Frits R.
    van Dorp, Eveline L. A.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (09) : 1081 - 1094
  • [8] Risk factors for prescription opioid misuse by duration of misuse
    Osborne, Vicki
    Lasopa, Sonam Ongmu
    Striley, Catherine Woodstock
    Cottler, Linda
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E156 - E156
  • [9] Modeling the Prescription Opioid Epidemic
    Nicholas A. Battista
    Leigh B. Pearcy
    W. Christopher Strickland
    [J]. Bulletin of Mathematical Biology, 2019, 81 : 2258 - 2289
  • [10] Chronic pain and prescription opioid misuse
    Tordoff, Simon G.
    Ganty, Praveen
    [J]. BJA EDUCATION, 2010, 10 (05) : 158 - 161